| Sep 19 |
Daxor Corporation to Exhibit at the Heart Failure Society of America Annual Scientific Meeting 2024
|
| Sep 12 |
Newly Published Review Highlights the Pivotal Role of Daxor’s Blood Volume Analysis Technology in Advancing Cardiorenal Syndrome Management
|
| Sep 5 |
Daxor Corporation Receives $300K Matching Fund Award From Launch Tennessee
|
| Sep 4 |
Leading Central Florida Hospital Implements Daxor’s BVA-100™ Blood Volume Diagnostic for Heart Failure Patient Care
|
| Sep 3 |
Daxor Corporation CEO and President Michael Feldschuh Delivers Corporate Update in Shareholder Letter
|
| Sep 3 |
Daxor Corporation to Present at the H.C. Wainwright 26th Annual Global Investment Conference
|
| Jul 24 |
Daxor Corporation Awarded New U.S. Defense Health Agency Contract for Added Capabilities to Its Point-of-Care Blood Volume Analyzer
|
| Jul 11 |
Daxor Corporation’s BVA-100™ Blood Volume Diagnostic Expands to Three New Centers, Gains Traction Nationwide
|
| Jun 18 |
Daxor Corporation to Showcase the Benefits of BVA-100™ Guided-Care at the American Association of Heart Failure Nurses (AAHFN) 20th Annual Meeting
|
